• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACE 基因 D/I 多态性作为囊性纤维化严重程度的调节剂。

The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis.

机构信息

Department of Pediatrics, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.

出版信息

BMC Pulm Med. 2012 Aug 8;12:41. doi: 10.1186/1471-2466-12-41.

DOI:10.1186/1471-2466-12-41
PMID:22874010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3460779/
Abstract

BACKGROUND

Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF.

METHODS

A cross-sectional study was performed, from 2009 to 2011, at University of Campinas - UNICAMP. We analyzed 180 patients for the most frequent mutations in the CFTR gene, presence of the ACE gene D/I polymorphism and clinical characteristics of CF.

RESULTS

There was an association of the D/D genotype with early initiation of clinical manifestations (OR: 1.519, CI: 1.074 to 2.146), bacterium Burkholderia cepacia colonization (OR: 3.309, CI: 1.476 to 6.256) and Bhalla score (BS) (p = 0.015). The association was observed in subgroups of patients which were defined by their CFTR mutation genotype (all patients; subgroup I: no mutation detected; subgroup II: one CFTR allele identified to mutation class I, II or III; subgroup III: both CFTR alleles identified to mutation class I, II and/or III).

CONCLUSION

An association between the D allele in the ACE gene and the severity of CF was found in our study.

摘要

背景

囊性纤维化(CF)是一种单基因疾病,由于遗传和环境因素的共同作用,其表达具有复杂性。我们研究了 ACE 基因 D/I 多态性是否与 CF 的严重程度有关。

方法

这是一项在 2009 年至 2011 年期间于坎皮纳斯大学(UNICAMP)进行的横断面研究。我们分析了 180 例 CFTR 基因突变的患者,ACE 基因 D/I 多态性的存在以及 CF 的临床特征。

结果

D/D 基因型与临床表现的早期发生(OR:1.519,CI:1.074 至 2.146)、伯克霍尔德菌属(OR:3.309,CI:1.476 至 6.256)和 Bhalla 评分(BS)(p = 0.015)相关。这种关联在 CFTR 基因突变基因型定义的患者亚组中也存在(所有患者;亚组 I:未检测到突变;亚组 II:一个 CFTR 等位基因鉴定为突变 I、II 或 III 类;亚组 III:两个 CFTR 等位基因鉴定为突变 I、II 和/或 III 类)。

结论

本研究发现 ACE 基因中的 D 等位基因与 CF 的严重程度之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c2/3460779/50a2546b9347/1471-2466-12-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c2/3460779/50a2546b9347/1471-2466-12-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16c2/3460779/50a2546b9347/1471-2466-12-41-1.jpg

相似文献

1
The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis.ACE 基因 D/I 多态性作为囊性纤维化严重程度的调节剂。
BMC Pulm Med. 2012 Aug 8;12:41. doi: 10.1186/1471-2466-12-41.
2
CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.囊性纤维化病携带成年患者的 CFTR 基因型与临床结局
Gene. 2014 May 1;540(2):183-90. doi: 10.1016/j.gene.2014.02.040. Epub 2014 Feb 26.
3
Genetic interaction of GSH metabolic pathway genes in cystic fibrosis.谷胱甘肽代谢途径基因在囊性纤维化中的遗传相互作用。
BMC Med Genet. 2013 Jun 10;14:60. doi: 10.1186/1471-2350-14-60.
4
Association of IVS6A GATT polymorphism of CFTR gene with cystic fibrosis: first study in CF and normal Tunisian population.CFTR基因IVS6A GATT多态性与囊性纤维化的关联:突尼斯囊性纤维化患者和正常人群的首次研究
Ann Biol Clin (Paris). 2020 Jun 1;78(3):314-318. doi: 10.1684/abc.2020.1555.
5
Genotype-phenotype correlation and functional studies in patients with cystic fibrosis bearing CFTR complex alleles.携带CFTR复合等位基因的囊性纤维化患者的基因型-表型相关性及功能研究。
J Med Genet. 2017 Apr;54(4):224-235. doi: 10.1136/jmedgenet-2016-103985. Epub 2016 Oct 13.
6
Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis.囊性纤维化患者家庭中的囊性纤维化跨膜传导调节因子单倍型
Gene. 2018 Jan 30;641:137-143. doi: 10.1016/j.gene.2017.10.052. Epub 2017 Oct 18.
7
Poly thymidine polymorphism and cystic fibrosis in a non-Caucasian population.多聚胸苷核苷酸多态性与非高加索人群中的囊性纤维化。
Dis Markers. 2012;32(4):241-6. doi: 10.3233/DMA-2011-0880.
8
Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.高加索地区 Chechen 囊性纤维化患者 CFTR 基因突变谱:c.1545_1546delTA(p.Tyr515X;1677delTA)和 c.274G>A(p.Glu92Lys,E92K)突变高频。
BMC Med Genet. 2019 Mar 21;20(1):44. doi: 10.1186/s12881-019-0785-z.
9
Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.ADRB2 基因多态性可调节支气管扩张剂的反应和囊性纤维化的严重程度。
BMC Pulm Med. 2012 Sep 5;12:50. doi: 10.1186/1471-2466-12-50.
10
Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.伊朗囊性纤维化患者CFTR基因分析:鉴定出八个新突变
J Cyst Fibros. 2008 Mar;7(2):102-9. doi: 10.1016/j.jcf.2007.06.001. Epub 2007 Jul 27.

引用本文的文献

1
Diagnosis and Emerging Biomarkers of Cystic Fibrosis-Related Kidney Disease (CFKD).囊性纤维化相关肾病(CFKD)的诊断与新兴生物标志物
J Clin Med. 2025 Aug 7;14(15):5585. doi: 10.3390/jcm14155585.
2
Potential Resistance Mechanisms Exhibited by Cystic Fibrosis Patients Against SARS-CoV-2.囊性纤维化患者对SARS-CoV-2表现出的潜在抵抗机制。
Viruses. 2025 Jun 27;17(7):919. doi: 10.3390/v17070919.
3
Impact of Gene Modifiers on Cystic Fibrosis Phenotypic Profiles: A Systematic Review.基因修饰因子对囊性纤维化表型谱的影响:一项系统综述。

本文引用的文献

1
Genetic variation and clinical heterogeneity in cystic fibrosis.囊性纤维化的遗传变异和临床异质性。
Annu Rev Pathol. 2012;7:267-82. doi: 10.1146/annurev-pathol-011811-120900. Epub 2011 Oct 17.
2
[Cystic fibrosis in images: the Bhalla scoring system for computed tomography in paediatric patients].[影像中的囊性纤维化:儿科患者计算机断层扫描的巴拉评分系统]
Radiologia. 2012 May-Jun;54(3):260-8. doi: 10.1016/j.rx.2011.04.007. Epub 2011 Sep 21.
3
Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes.
Hum Mutat. 2024 Oct 16;2024:6165547. doi: 10.1155/2024/6165547. eCollection 2024.
4
The clinical features and impact of SARS-CoV-2/COVID-19 infection in children with Cystic Fibrosis (CF): A Qatari experience.严重急性呼吸综合征冠状病毒2型/冠状病毒病19(SARS-CoV-2/COVID-19)感染对囊性纤维化(CF)儿童的临床特征及影响:卡塔尔的经验
Qatar Med J. 2023 Dec 12;2023(3):19. doi: 10.5339/qmj.2023.19. eCollection 2023.
5
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis.巴西新冠疫情期间因严重急性呼吸道感染住院的囊性纤维化患者的流行病学概况及全球囊性纤维化患者新冠感染情况的系统评价
Healthcare (Basel). 2023 Jul 4;11(13):1936. doi: 10.3390/healthcare11131936.
6
Single Nucleotide Variants (SNVs) of Angiotensin-Converting Enzymes (ACE1 and ACE2): A Plausible Explanation for the Global Variation in COVID-19 Prevalence.血管紧张素转化酶(ACE1 和 ACE2)的单核苷酸变异(SNVs):对全球 COVID-19 流行率差异的合理解释。
J Renin Angiotensin Aldosterone Syst. 2023 Apr 3;2023:9668008. doi: 10.1155/2023/9668008. eCollection 2023.
7
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic.系统评价:严重急性呼吸综合征冠状病毒 2 型/COVID-19 大流行中的囊性纤维化。
BMC Pulm Med. 2021 May 20;21(1):173. doi: 10.1186/s12890-021-01528-0.
8
A Pooled Study of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Relation to Risk, Pathology and Prognosis of Childhood Immunoglobulin A Vasculitis Nephritis.血管炎肾炎患儿 ACE 插入/缺失基因多态性与风险、病理和预后的相关性的汇总研究
Biochem Genet. 2021 Feb;59(1):202-218. doi: 10.1007/s10528-020-09999-2. Epub 2020 Sep 26.
9
SARS-CoV-2 (COVID-19) and cystic fibrosis.严重急性呼吸综合征冠状病毒 2 型(COVID-19)与囊性纤维化。
Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L408-L415. doi: 10.1152/ajplung.00225.2020. Epub 2020 Jul 15.
10
Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.高渗盐水在囊性纤维化患者痰液诱导和病原体检测中的应用
Lung. 2017 Aug;195(4):431-439. doi: 10.1007/s00408-017-0008-3. Epub 2017 Apr 28.
抗高血压基因变异:血管紧张素 1 转换酶、血管紧张素原和内皮型一氧化氮合酶基因的多位点分析。
DNA Cell Biol. 2011 Aug;30(8):555-64. doi: 10.1089/dna.2010.1156. Epub 2011 Mar 27.
4
Modifier genes in Mendelian disorders: the example of cystic fibrosis.孟德尔疾病中的修饰基因:囊性纤维化为例。
Ann N Y Acad Sci. 2010 Dec;1214:57-69. doi: 10.1111/j.1749-6632.2010.05879.x.
5
Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.决定免疫学和炎症的基因改变了囊性纤维化上皮细胞离子电导受损的基本缺陷。
J Med Genet. 2011 Jan;48(1):24-31. doi: 10.1136/jmg.2010.080937. Epub 2010 Sep 12.
6
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.遗传决定的血管紧张素转换酶水平与心肌对缺血的耐受性。
FASEB J. 2010 Dec;24(12):4691-700. doi: 10.1096/fj.10-165902. Epub 2010 Jul 28.
7
Genetic counselling issues in cystic fibrosis.囊性纤维化的遗传咨询问题。
Paediatr Respir Rev. 2010 Jun;11(2):75-9. doi: 10.1016/j.prrv.2010.01.001. Epub 2010 Mar 27.
8
Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.囊性纤维化中的蛋白加工和炎症信号转导:挑战与治疗策略。
Curr Mol Med. 2010 Feb;10(1):82-94. doi: 10.2174/156652410791065408.
9
Insertion/deletion polymorphism and serum activity of the angiotensin-converting enzyme in Turkish patients with obstructive sleep apnea syndrome.土耳其阻塞性睡眠呼吸暂停综合征患者血管紧张素转换酶插入/缺失多态性与血清活性。
Biochem Genet. 2010 Jun;48(5-6):516-23. doi: 10.1007/s10528-010-9335-2. Epub 2010 Feb 25.
10
Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population.突尼斯健康人群与急性心肌梗死人群中血管紧张素转换酶插入/缺失基因多态性
Genet Test Mol Biomarkers. 2010 Feb;14(1):85-91. doi: 10.1089/gtmb.2009.0105.